1. Home
  2. AMPX vs IVA Comparison

AMPX vs IVA Comparison

Compare AMPX & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amprius Technologies Inc.

AMPX

Amprius Technologies Inc.

N/A

Current Price

$17.12

Market Cap

1.5B

Sector

Miscellaneous

ML Signal

N/A

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

N/A

Current Price

$6.29

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMPX
IVA
Founded
2008
2011
Country
United States
France
Employees
108
84
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AMPX
IVA
Price
$17.12
$6.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
10
Target Price
$17.86
$16.20
AVG Volume (30 Days)
7.7M
381.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$70.54
N/A
Revenue Next Year
$73.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$2.70
52 Week High
$17.29
$7.98

Technical Indicators

Market Signals
Indicator
AMPX
IVA
Relative Strength Index (RSI) 73.49 52.37
Support Level $10.00 $5.71
Resistance Level N/A $6.48
Average True Range (ATR) 1.16 0.30
MACD 0.67 -0.07
Stochastic Oscillator 94.87 37.13

Price Performance

Historical Comparison
AMPX
IVA

About AMPX Amprius Technologies Inc.

Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: